Septerna (SEPN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Septerna (SEPN) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.04 of bullish evidence against -0.25 bearish.

Septerna last closed at $37.87, +0.42% on the session.

Against the IVW growth benchmark the position is -0.50% over the forecast window.

The read is built from 11 underlying insights — 2 bullish and 9 bearish.

Agreement across those insights is 82%.

2 graded predictions for SEPN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Septerna in the 34th percentile on return on equity, where 100 is best.

Septerna is classified under Health Care / Pharmaceuticals, with a market capitalisation of $1.76B.

StockMap tracks Septerna as the 40th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Septerna ranks 60th of 128 in the group, against a group median of -0.24.